Modelos animais ajudando a decifrar doenças neuromusculares humanas
DOI:
https://doi.org/10.34024/rnc.2005.v13.8800Palavras-chave:
suplementoResumo
.
Métricas
Referências
Allamand V, Campbell KP. Animal models for muscular dystrophy: valuable tools for the development of therapies. Human Mol Genet 2000; 9: 2459-2467.
Barone V, Bertocchini F, Bottinelli R, et al. Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors. FEBS Lett 1998;422:160-164.
Cooper BJ, Winand NJ, Stedman H, et al. The homologue of the Duchenne locus is defective in Xlinked muscular dystrophy of dogs. Nature 1988; 334: 154-156.
Fujii J, Otsu K, Zorzato F, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991; 253: 448-451.
Gussoni E, Yko S, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401: 390-394.
Pastoret C, Sebille A. Mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995; 129: 97-105.
Vainzof M, Yamamoto LU, Gouveia TLF, Zatz M. The contribution of protein analysis in the diagnosis of neuromuscular diseases. In: Burgess VN, Trends in Muscular Dystrophy Research. USA: Nova Publisher, 2005.
